A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis

J. Theodore Phillips, George Rice, Elliot Frohman, Luc Vande Gaer, Thomas Scott, Judith Haas, Eric Eggenberger, Mark S. Freedman, William Stuart, Luis Cunha, Lawrence Jacobs, Joel Oger, Douglas Arnold, Jock Murray, Mary DiBiase, Vijay Jethwa, Susan Goelz